Pengaruh Rasio Keuangan Terhadap Pertumbuhan Laba Dengan Ukuran Perusahaan Sebagai Variabel Moderasi Pada Perusahaan Sub Sektor Farmasi Yang Terdaftar Pada Bursa Efek Indonesia Periode 2019-2021

Abstract

This research was conducted with the aim of finding out what can affect profit growth in pharmaceutical sub-sector companies for the 2019-2021 period. The independent variables used in this research are ROA, DAR, CR, and TATO to find out why companies are experiencing profit growth. In this study, firm size is used as a moderating variable with the aim of knowing whether it can strengthen the relationship between the independent variables and earnings growth. Using a purposive sampling technique, the sample in this study used 10 pharmaceutical sub-sector companies listed on the Indonesia Stock Exchange for the 2019-2021 period. The data analysis technique used in this study is panel data regression and moderation regression. The results of this study state that ROA and DAR have a positive effect on profit growth, while the CR and TATO variables have no effect on profit growth because profit growth occurs when the assets owned by a company can be put to good use to generate profits. Then the size of the company cannot be a moderating variable in this study because the size of the company does not guarantee profit growth in a company, but rather how the company's ability to manage its assets to generate profits. The results of this study can be used as a comparison or reference for research with similar topics. The results of this study are expected to be used to see financial ratios that can affect company profit growth that can be used by investors in making investment decisions